Rectangle Breakout Trigger on a Fundamentally Strong Pharma Stock!

The weekly chart is showing a clean Rectangle Consolidation breakout around the ₹210–₹212 zone, where the stock spent several months moving sideways and absorbing supply. Such prolonged consolidation phases often act as accumulation zones, and a breakout above the range can signal the beginning of a fresh trending move. From an Elliott Wave perspective, the sideways structure appears to resemble a corrective Wave-2 or Wave-4 consolidation phase. The recent breakout attempt suggests the stock could be entering an impulsive Wave-3 advance, which is generally known for strong price expansion and increased participation. The momentum setup also hints at a bullish MACD divergence, where momentum gradually strengthened while price remained trapped in a range. This type of divergence often acts as an early signal that sellers are losing control before a breakout becomes visible. Price is also moving above a key AVWAP level, which can now act as an important support zone. Holding above this anchored institutional reference point generally reflects stronger accumulation and improving trend quality. The fundamental side further supports the setup: ✔ Healthy ROCE and efficient capital deployment ✔ Consistent earnings growth with improving business execution ✔ Strong presence in export-focused pharmaceutical segments with long-term demand potential When breakout structure, Elliott Wave progression, MACD confirmation, AVWAP support, and strong fundamentals align together, the probability of a sustained move improves significantly. Sustaining above the breakout zone with stronger participation could open the path for the next upward expansion phase.